Register entry

SENORES PHARMACEUTICALS LIMITED

Data as of · How to read this entry

Registered sites
1
Active NDC listings
3
Live patents
0
Countries
1
Base
India
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1Labelling1Packaging1particle size reduction1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
SENORES PHARMACEUTICALS LIMITEDSurvey No. 1530, Rajpur, Kadi, Mehsana, GUJARAT 384440, India (IND)Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging, particle size reduction3017421355772463005
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: ANDA 3.

Dosage formNDCs
capsule3
RouteNDCs
oral3
Labeller name on the listingNDCs
senores pharmaceuticals, inc.3
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
MEXILETINE HYDROCHLORIDEmexiletine hydrochloridecapsule, oral82012-027ANDA
MEXILETINE HYDROCHLORIDEmexiletine hydrochloridecapsule, oral82012-028ANDA
MEXILETINE HYDROCHLORIDEmexiletine hydrochloridecapsule, oral82012-029ANDA
Neighbours

Registered in the same town

3
Compare

Comparable companies in India

Enquiry

Common questions

Is SENORES PHARMACEUTICALS LIMITED FDA approved?
SENORES PHARMACEUTICALS LIMITED holds 1 FDA-registered establishment in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are SENORES PHARMACEUTICALS LIMITED's drugs manufactured?
The FDA register lists Mehsana. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, packaging, particle size reduction.
What drugs does SENORES PHARMACEUTICALS LIMITED make?
3 products are listed under SENORES PHARMACEUTICALS LIMITED in the openFDA NDC Directory, most often as capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.